NATHAN FORKER: Open Payments
NPI 1285293548 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 10 payments from 6 companies in 2025. Trend: 2023 $538 · 2024 $797 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $280 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $85 |
| Amgen Inc. | 2 | $38 |
| Novo Nordisk Inc | 2 | $36 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: FARXIGA, LOKELMA, JARDIANCE, REPATHA, Wegovy, ONPATTRO, SHINGRIX.
Industry payments across KY — which companies pay providers there.
